Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

More on the Avandia Restrictions

Posted in Misc. Drugs

I was not aware that Avandia was the #2 seller for GSK.  This is really going to hurt for them:

(Reuters) – European officials moved to pull GlaxoSmithKline’s diabetes drug Avandia off the market and U.S. authorities imposed tight restrictions over heart risks, effectively spelling the commercial end to the once-lucrative medicine.

Once a top treatment choice and Glaxo’s No. 2 seller, the rulings attempted to resolve a bitter, three-year debate over Avandia’s safety that has dogged the reputation of the medicine and its maker, and divided staff inside the U.S. Food and Drug Administration.

Source: EU pulls plug on Glaxo’s Avandia, FDA restricts | Reuters

The question I have is whether the FDA’s new actions are sufficient to trigger a new statute of limitations for people who want to file an Avandia lawsuit.  Traditionally, when the FDA adds a black box warning or recalls a drug, that acts as sufficient information to trigger a new statute under the discovery rule.  Regardless, I’m sure that this will trigger a new wave of Avandia lawsuits.